Birchview Capital, LP Intercept Pharmaceuticals, Inc. Transaction History

Birchview Capital, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$24.48 - $42.47 $203,184 - $352,501	-8,300 Closed	0 $0
Q1 2019 May 03, 2019	BUY	$91.83 - $120.68 $367,320 - $482,720	4,000 Added 93.02%	8,300 $928,000
Q3 2017 Nov 02, 2017	BUY	$57.01 - $118.75 $245,143 - $510,625	4,300	4,300 $250,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Birchview Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Birchview Capital, LP with notifications on news.